Ondas Holdings Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY (Details)

STOCKHOLDERS’ EQUITY (Details) - USD ($)												1 Months Ended				12 Months Ended
STOCKHOLDERS’ EQUITY (Details) - USD ($)	Jan. 19, 2021	Dec. 16, 2020	Dec. 08, 2020	Dec. 03, 2020	Nov. 03, 2020	Sep. 09, 2020	Aug. 14, 2020	Jun. 03, 2020	May 06, 2020	Dec. 15, 2019	Sep. 27, 2019	Jan. 25, 2021	Jan. 17, 2020	Nov. 27, 2019	Oct. 30, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jan. 31, 2021	Nov. 12, 2020	Sep. 28, 2018
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Preferred stock, authorized																5,000,000	10,000,000
Preferred stock, par value (in Dollars per share)																$ 0.0001	$ 0.0001
Preferred stock, shares Issued
Preferred stock, shares outstanding
Conversion of aggregate of shares			979,361
Aggregate of shares			195,881
Aggregate of shares			15,093
Certificate of designation series A preferred stock							5,000,000
Percentage purchase price							25.00%
Purchase price (in Dollars)							$ 6.00
Effective interest rate							25.00%
Effective conversion price (in Dollars)							$ 6.00
Stockholder debt term							1 year
Percentage of premium			25.00%
Reverse stock split, description					the Board of Directors of the Company approved a one-for-three reverse stock split of the Company’s authorized and outstanding common stock, effective November 13, 2020 (the “Reverse Stock Split”).											All share and per share amounts in the consolidated financial statements and related notes have been retrospectively adjusted to reflect the Exchange Ratio in connection with the Acquisition.
Common stock, authorized																116,666,667	116,666,667
Common stock, par value (in Dollars per share)																$ 0.0001	$ 0.0001
Price per share (in Dollars per share)																$ 5.58
Purchase price per share (in Dollars per share)			$ 6.00
Amount of shares to purchase by stock option (in Dollars)			$ 26,762,000
Stock options to purchase																568,006	225,001
Stock options exercise price (in Dollars per share)																$ 7.39	$ 9.75
Restricted stock purchase								1,000,000
2018 Equity Incentive Plan [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Common stock reserved for issuance																3,333,334
Investor [Member] \| Securities Purchase Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of shares issued														253,600	206,000
Gross proceeds from initial closing (in Dollars)											$ 6,065,000
Net proceeds from second closing (in Dollars)															$ 515,000
Net proceeds from third closing (in Dollars)														$ 634,000
Investor [Member] \| Registration Rights Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Description of liquidated damages payable																The amount of liquidated damages payable to an Investor is 1.0% of the aggregate amount invested by such Investor for each 30-day period, or pro rata portion thereof, during which the default continues. To date the Company has paid $60,650 and accrued $19,053 in liquidated damages.
Placement Agent [Member] \| Securities Purchase Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Aggregate cash fee (in Dollars)																$ 721,400
Percentage of gross proceeds																10.00%
Reimbursement of transaction expenses (in Dollars)																$ 40,000
Number of warrants to purchase																288,560
Securities Purchase Agreement [Member] \| Placement Agent [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrants exercise price (in Dollars per share)																$ 3.25
Energy Capital [Member] \| Loan And Security Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Debt principal and interest outstanding amount (in Dollars)																$ 10,563,104
Number of equity instruments convertible																1,408,414
Convertible Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Preferred stock, shares outstanding			2,350,390
Conversion of aggregate of shares			979,361
Aggregate of shares			195,881
Aggregate of shares			15,093
Convertible Notes Payable [Member] \| Other Financing Agreements [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Debt principal and interest outstanding amount (in Dollars)																$ 3,933,767
Number of equity instruments convertible																524,505
Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Preferred stock, authorized																10,000,000
Preferred stock, par value (in Dollars per share)																$ 0.0001
Preferred stock, shares Issued																5,000,000
Preferred stock, shares outstanding																5,000,000
Common Stock [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Common stock, authorized																				116,666,667
Common stock outstanding																				19,796,029
Common stock, par value (in Dollars per share)																					$ 0.0001
Number of shares issued						120,000				120,000
Common Stock [Member] \| Individual Lender [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of shares issued											46,893
Warrant [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of warrants to purchase									231,543
Warrants exercise price (in Dollars per share)									$ 7.50		$ 9.75			$ 9.75	$ 9.75
Description of warrant rights									On May 6, 2020, the Company’s Board granted (i) an aggregate of 47,917 Warrants with an exercise price of $7.50 per share and a grant date fair value of $1.00 per share, and (ii) an aggregate of 9,793 Warrants with an exercise price of $6.39 per share and a grant date fair value of $1.71 per share.
Warrant fair value (in Dollars per share)											$ 1.00			$ 1.03	$ 1.05
Stock options to purchase									231,543
Expected weighted average vesting period									5 years							3 years
Warrants to purchase shares											1,498,603			50,726	41,206
Warrant [Member] \| Minimum [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrant fair value (in Dollars per share)									$ 1.40
Warrant [Member] \| Maximum [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrant fair value (in Dollars per share)									$ 2.37
Warrant [Member] \| Securities Purchase Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of warrants to purchase																1,879,803
Warrants exercise price (in Dollars per share)																$ 9.16
Weighted-average contractual remaining life																2 years 2 months 12 days
Warrant [Member] \| Securities Purchase Agreement [Member] \| Minimum [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrants exercise price (in Dollars per share)																$ 0.03
Warrant [Member] \| Securities Purchase Agreement [Member] \| Maximum [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrants exercise price (in Dollars per share)																$ 9.75
Warrant [Member] \| Individual Lender [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrants exercise price (in Dollars per share)											$ 0.03
Warrant fair value (in Dollars per share)											$ 7.47
Warrants to purchase shares											46,893
Equity Option [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Agreement, description											On September 27, 2019, pursuant to the terms of Severance Agreements, 225,001 incentive stock options with deferred distribution were promised to two former employees of the Company pursuant to the 2018 Plan (both employees participated in the restricted stock purchase offers (“RSUs”) discussed below).
Stock options to purchase									499,674				6,542
Stock-based compensation expense (in Dollars)																$ 514,866
Options term									10 years			10 years	5 years
Stock options exercise price (in Dollars per share)									$ 6.39				$ 7.50
Weighted average grant-date fair value (in Dollars per share)									$ 2.25				$ 2.37
Stock compensation expense (in Dollars)																1,397,000	$ 435,000
Unrecognized compensation expense (in Dollars)																$ 233,000
Weighted-average contractual remaining life																1 year 3 months 18 days
Subsequent Event [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Warrants exercise price (in Dollars per share)																			$ 9.75
Warrants to purchase shares																			96,269
Subsequent Event [Member] \| Equity Option [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Stock options to purchase												90,000
Stock options exercise price (in Dollars per share)												$ 12.72
Weighted average grant-date fair value (in Dollars per share)												$ 5.72
Securities Purchase Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Agreement, description							the Company entered into securities purchase agreements (the “2020 Purchase Agreements”) with certain purchasers (the “2020 Investors”), which provided for the sale of an aggregate of $4,435,000 ($4,483,749 after payment of offering expenses) and the exchange for debt of $265,779 of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred”) at a purchase price of $2.00 per share (the “Purchase Price”) (the “Offering”). On August 14, 2020 and August 27, 2020, pursuant to the 2020 Purchase Agreements, the Company issued an aggregate of 2,350,390 shares of Series A Preferred to the Investors (collectively the “2020 Closing”). In connection with the 2020 Closing, Eric Brock, the Company’s Chief Executive Officer purchased 157,500 shares of Series A Preferred.
Securities Purchase Agreement [Member] \| Investor [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of shares issued											2,426,000
Restricted Stock Units (RSUs) [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Weighted-average contractual remaining life																1 year 3 months
Weighted average grant-date fair value (in Dollars per share)																		$ 0.64
Stock compensation expense (in Dollars)																$ 3,150,000
Unrecognized compensation expense (in Dollars)																$ 5,250,000
Restricted stock purchase																		126,160
Shares options issued non-vested																625,000
Weighted average grant-date fair value of exercise price (in Dollars per share)																$ 8.40
Vesting period																2 years		2 years
Restricted stock																		136,161
Expenses of stock (in Dollars)																	71,789
Restricted Stock Units (RSUs) [Member] \| Subsequent Event [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Description of restricted stock units	Effective January 19, 2021, (i) Mr. Bushey will have the right to receive 500,000 RSU Shares (375,000 RSU Shares vested as of December 31, 2020 and 125,000 RSU Shares on which the Compensation Committee accelerated vesting), which RSU Shares will be issued on June 3, 2022 pursuant to Mr. Bushey’s deferral election, and (ii) 500,000 RSU shares will be canceled.
Public Offering [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
shares issued				5,000,000
Common stock, par value (in Dollars per share)				$ 0.0001
Over-Allotment Option [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of shares issued		750,000		750,000
Proceeds from sale of units (in Dollars)		$ 4,200,000
Over-Allotment Option [Member] \| Investor [Member] \| Securities Purchase Agreement [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Number of shares issued											400,000
Purchase price per share (in Dollars per share)											$ 2.50
Proceeds from sale of units (in Dollars)											$ 12,500,000
Proceeds from sale of additional units (in Dollars)											$ 2,500,000
Description of transaction											Each Unit consists of one share of Common Stock and one-half of one warrant to purchase one share of Common Stock at an exercise price of $3.25 per share for a period commencing six months and ending 36 months after the closing date (the “Investor Warrants”).
Gross proceeds from initial closing (in Dollars)											$ 1,000,000
Consultant [Member] \| Restricted Stock Units (RSUs) [Member]
STOCKHOLDERS’ EQUITY (Details) [Line Items]
Stock compensation expense (in Dollars)																$ 30,357	$ 50,599